CIK 0001818331 · Large accelerated filer
GeneDx Holdings Corp.
Sign in to watch- Ticker
- WGS
- Exchange
- Nasdaq
- Industry
- Services-Health Services
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851966622
- Phone
- 888-729-1206
- Business address
- 333 LUDLOW STREET, NORTH TOWER, 6TH FLOOR, STAMFORD, CT, 06902
- Former names
- Sema4 Holdings Corp., CM Life Sciences, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,839,245
- in 5 filings
Net −$1,839,245. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-04 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale | −2,220 | $79.25 | $176K | 18,674 |
| 2026-03-04 | Stueland Katherine CHIEF EXECUTIVE OFFICER | Sale | −5,861 | $77.63 | $455K | 58,281 |
| 2026-03-04 | Stueland Katherine CHIEF EXECUTIVE OFFICER | Sale | −10,465 | $78.61 | $823K | 47,816 |
| 2026-03-04 | Stueland Katherine CHIEF EXECUTIVE OFFICER | Sale | −9,133 | $79.25 | $724K | 38,683 |
| 2026-03-03 | Dechairo Bryan Chief Operating Officer | Grant or award · Restricted Stock Unit | +10,430 | 10,430 | ||
| 2026-03-03 | Feeley Kevin CHIEF FINANCIAL OFFICER | Grant or award | +15,262 | 24,861 | ||
| 2026-03-03 | Feeley Kevin CHIEF FINANCIAL OFFICER | Grant or award · Restricted Stock Unit | +10,865 | 10,865 | ||
| 2026-03-03 | Stueland Katherine CHIEF EXECUTIVE OFFICER | Grant or award | +47,684 | 64,142 | ||
| 2026-03-03 | Stueland Katherine CHIEF EXECUTIVE OFFICER | Grant or award · Restricted Stock Unit | +40,418 | 40,418 | ||
| 2026-03-03 | Meister Keith A. Director | Purchase | +19,686 | $70.34 | $1.4M | 3,078,315 |
| 2026-03-03 | Meister Keith A. Director | Purchase | +8,439 | $71.48 | $603K | 3,086,754 |
| 2026-03-03 | Meister Keith A. Director | Purchase | +200 | $72.00 | $14K | 3,086,954 |
| 2026-03-03 | Meister Keith A. Director | Purchase | +921 | $75.66 | $70K | 3,087,875 |
| 2026-03-03 | Meister Keith A. Director | Purchase | +249 | $75.99 | $19K | 3,088,124 |
| 2026-03-02 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale | −287 | $77.52 | $22K | 9,599 |
| 2026-03-01 | Feeley Kevin CHIEF FINANCIAL OFFICER | Option exercise | +718 | 9,886 | ||
| 2026-03-01 | Feeley Kevin CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Unit | −718 | 1,434 | ||
| 2026-02-04 | Dechairo Bryan Chief Operating Officer | Sale 10b5-1 | −779 | $83.04 | $65K | 5,182 |
| 2026-02-04 | Dechairo Bryan Chief Operating Officer | Sale 10b5-1 | −1,425 | $83.83 | $119K | 3,757 |
| 2026-02-04 | Dechairo Bryan Chief Operating Officer | Sale 10b5-1 | −1,034 | $84.93 | $88K | 2,723 |
Page 8 of 23 · 450 trades